D
Dyne Therapeutics, Inc. DYN
$10.05 $0.202.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 70.69% -35.31% 73.03% 83.12% 27.52%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 60.91% 76.95% 43.46% 69.67% 7.83%
Operating Income -60.91% -76.95% -43.46% -69.67% -7.83%
Income Before Tax -70.28% -75.72% -34.37% -61.31% -0.31%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -70.28% -75.72% -34.37% -61.31% -0.31%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -70.28% -75.72% -34.37% -61.31% -0.31%
EBIT -60.91% -76.95% -43.46% -69.67% -7.83%
EBITDA -61.10% -77.21% -43.65% -70.14% -7.93%
EPS Basic -38.34% -29.58% 19.11% 2.28% 35.12%
Normalized Basic EPS -38.34% -29.57% 19.10% 2.29% 35.12%
EPS Diluted -38.34% -29.58% 19.11% 2.28% 35.12%
Normalized Diluted EPS -38.34% -29.57% 19.10% 2.29% 35.12%
Average Basic Shares Outstanding 23.10% 35.62% 66.11% 65.08% 54.60%
Average Diluted Shares Outstanding 23.10% 35.62% 66.11% 65.08% 54.60%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --